U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07908420) titled 'Accelerated Dual-Protocol rTMS for Refractory Trigeminal Neuralgia' on Oct. 26.

Brief Summary: Brief Summary

The goal of this clinical trial is to learn if an accelerated, dual-protocol high-frequency repetitive transcranial magnetic stimulation (rTMS) intervention can treat and achieve long-term pain relief (analgesia) in patients with pharmacologically refractory primary Trigeminal Neuralgia (TN). The main questions it aims to answer are:

* Can a combined 10 Hz and 20 Hz rTMS protocol significantly reduce average facial pain intensity (measured via the Visual Analog Scale) at 1 month post-treatment?

* Will the induced analgesic ...